Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond

被引：25
|
作者：
Pemmaraju, Naveen [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Unit 428, POB 301402, Houston, TX 77230 USA
来源：
CURRENT HEMATOLOGIC MALIGNANCY REPORTS | 2017年 / 12卷 / 06期
关键词：
BPDCN; IL3R; CD123; Targeted therapy; Bromodomain; BCL2; NFkB; WORLD-HEALTH-ORGANIZATION; T-CELLS; MYELOID NEOPLASMS; RECEPTOR-ALPHA; LEUKEMIA; TRANSPLANTATION; CLASSIFICATION; INHIBITION; REVISION;
D O I：
10.1007/s11899-017-0425-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：510 / 512
页数：3
相关论文
共 50 条
  • [21] Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Initial Results of a Novel, Ongoing BPDCN International Registry Program
    Voskanyan, Astghik
    Badikyan, Maria
    Konopleva, Marina
    Alencar, Alvaro
    Ivanyan, Arusyak
    Owen, Carolyn
    Sergi, Consolato
    Kazandjian, Dickran
    Attardi, Enrico
    Tekkesin, Funda
    Ghali, Hasanein
    Bedirian, Karen
    Martelli, Maria Paola
    Voso, Maria Teresa
    Abramashvili, Mariam
    Al-Jadiry, Mazin
    Michael, Michalis
    Martirosyan, Nare
    Totogashvili, Nino
    Kotoucek, Pavel
    Kebudi, Rejin
    Ohannessian, Robin
    Papyan, Ruzanna
    Elashwah, Salma
    Bakhshi, Sameer
    Bardakhchyan, Samvel
    Danelyan, Samvel
    El-Ashwah, Shaimaa
    Kutluk, Tezer
    Tamamyan, Gevorg
    Pemmaraju, Naveen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S296 - S297
  • [22] Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data
    Beziat, Guillaume
    Ysebaert, Loic
    ONCOTARGETS AND THERAPY, 2020, 13 : 5199 - 5205
  • [23] Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics
    Adimora, Ijele J.
    Wilson, Nathaniel R.
    Pemmaraju, Naveen
    CANCER, 2022, 128 (16) : 3019 - 3026
  • [24] Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hope
    Cangini, Delia
    Silimbani, Paolo
    Cafaro, Alessandro
    Giannini, Maria B.
    Masini, Carla
    Di Rora, Andrea Ghelli Luserna
    Simonetti, Giorgia
    Martinelli, Giovanni
    Cerchione, Claudio
    MINERVA MEDICA, 2020, 111 (05) : 467 - 477
  • [25] Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)
    Bashir, Qaiser
    Milton, Denai R.
    Popat, Uday R.
    Kebriaei, Partow
    Hosing, Chitra
    Khouri, Issa F.
    Rezvani, Katayoun
    Nieto, Yago
    Oran, Betul
    Srour, Samer A.
    Saini, Neeraj Y.
    Olson, Amanda L.
    Ahmed, Sairah
    Al-Atrash, Gheath
    Rondon, Gabriela
    Konopleva, Marina Y.
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Qazilbash, Muzaffar H.
    Pemmaraju, Naveen
    BONE MARROW TRANSPLANTATION, 2022, 57 (01) : 51 - 56
  • [26] Tagraxofusp, a CD123-Targeted Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Landmark Clinical Trial
    Pemmaraju, Naveen
    Lane, Andrew
    Sweet, Kendra
    Stein, Anthony
    Vasu, Sumithira
    Blum, William
    Rizzieri, David
    Wang, Eunice
    Duvic, Madeleine
    Brooks, Christopher
    Sloan, J. Mark
    Rosenblat, Todd
    Akilov, Oleg
    Mughal, Tariq
    Lancet, Jeffrey
    Kantarjian, Hagop
    Konopleva, Marina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S209 - S210
  • [27] CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm
    Bole-Richard, Elodie
    Fredon, Maxime
    Biichle, Sabeha
    Anna, Francois
    Certoux, Jean-Marie
    Renosi, Florian
    Tse, Frederic
    Molimard, Chloe
    Valmary-Degano, Severine
    Jenvrin, Alizee
    Warda, Walid
    Pallandre, Jean-Rene
    Bonnefoy, Francis
    Poussard, Margaux
    Deschamps, Marina
    Petrella, Tony
    Roumier, Christophe
    Macintyre, Elizabeth
    Feger, Frederic
    Brissot, Eolia
    Mohty, Mohamad
    HoWangYin, Kiave-Yune
    Langlade-Demoyen, Pierre
    Loustau, Maria
    Caumartin, Julien
    Godet, Yann
    Binda, Delphine
    Pagadoy, Maider
    Deconinck, Eric
    Daguindau, Etienne
    Saas, Philippe
    Ferrand, Christophe
    Angelot-Delettre, Fanny
    Adotevi, Olivier
    Garnache-Ottou, Francine
    LEUKEMIA, 2020, 34 (12) : 3228 - 3241
  • [28] Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview
    Cazzato, Gerardo
    Capuzzolo, Marialessandra
    Bellitti, Emilio
    De Biasi, Giovanni
    Colagrande, Anna
    Mangialardi, Katia
    Gaudio, Francesco
    Ingravallo, Giuseppe
    HEMATOLOGY REPORTS, 2023, 15 (04) : 696 - 706
  • [29] Blastic plasmacytoid dendritic cell neoplasm (BPDCN) A rare hematologic neoplasm with frequent cutaneous involvement
    Nguyen, Katrin
    Korsing, Soren
    Mansour, Yasmine
    Meier, Katharina
    DERMATOLOGIE, 2023, 74 (10): : 787 - 792
  • [30] A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Practical Recommendations and Insights from Countries of the Gulf Cooperation Council
    Bakshi, Nasir
    Al Hejazi, Ayman
    Al-Maghraby, Hatim
    Al Mugairi, Areej
    Alotaibi, Ahmad S.
    Khogeer, Haitham
    Seliem, Rania Medhat
    Pandita, Ramesh
    Raslan, Heba
    Aung, Phyu P.
    Ohgami, Robert S.
    CANCERS, 2025, 17 (02)
12345